Testing effectiveness (Phase 2)Study completedNCT06810050
What this trial is testing
Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis
Who this might be right for
Atopic Dermatitis (AD)
CAGE Bio Inc. 180